baber/WOPTO huggingface dataset:
Patent MX-PA04005040-A (MX)
Title: Aluminum oxide material for optical data storage.
Inventor: MARK AKSELROD
IPC: G11B7/243
Filed: 2002-12-04
Abstract: The present invention provides aluminum oxide crystalline materials including dopants and oxygen vacancy defects and methods of making such crystalline materials. The crystalline materials of the present invention have particular utility in optical data storage applications.
Patent MX-PA04007164-A (MX)
Title: Antiperspirant compositions containing petrolatum.
Inventor: ERTEL KEITH DAVID
IPC: A61K8/28
Filed: 2003-01-17
Abstract: Disclosed are antiperspirant compositions comprising (a) from about 0.1% to about 30% by weight of an antiperspirant active; (b) from about 0.05% to about 0.95% by weight of petrolatum; (c) from about 10% to about 99% by weight of a liquid carrier; and (d) from about 0.1% to about 30% by weight of a suspending agent. The compositions provide a consumer perceived improvement in antiperspirant efficacy and product wash-off when the compositions are formulated with petrolatum within the above-described concentration ranges.
Patent MX-PA04007256-A (MX)
Title: Method for manufacturing cellulose carbamate.
Inventor: EINO SIVONEN
IPC: C08B15/06
Filed: 2003-01-29
Abstract: The invention relates to a method for manufacturing cellulose carbamate. In the method, an auxiliary agent and urea in solution form and possibly in solid form are absorbed into cellulose, and a reaction between cellulose and urea is carried out in a mixture containing cellulose, a liquid, the auxiliary agent, and urea. The absorption of the auxiliary agent and urea into cellulose, and the reaction between the cellulose and the auxiliary agent at least partly are carried out in a working device. According to the invention, it is possible to manufacture cellulose carbamate without ammonia, organic solvents or other auxiliary agents, by using only a small quantity of water as a medium.
Patent MX-PA04009329-A (MX)
Title: Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof.
Inventor: MARIO G CARDOZO
IPC: A61P9/10
Filed: 2003-03-21
Abstract: Compounds of Formula (IA) and Formula (IB) wherein R1, R2, R3, R4, R5 and R6 are as defined herein for Formula (IA) or Formula (IB), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
Patent MX-PA04009498-A (MX)
Title: COMPOSITIONS AND METHOD OF TREATING ALZHEIMERaCOES DISEASE.
Inventor: YIFENG LU
IPC: A61K38/00
Filed: 2003-04-08
Abstract: The invention relates to compositions and methods for treating AlzheimeraCOEs Disease and other amyloidoses, to polypeptides that modulate BACE1 activity, and methods to identify agents for use in treating AlzheimeraCOEs Disease and other amyloidoses.
Patent MX-PA04009573-A (MX)
Title: A paint roller for selectively applying paint at surface corners.
Inventor: ER POH LEONG
IPC: B05C17/025
Filed: 2003-01-24
Abstract: A paint roller (10) has a frustoconically-shaped applicator (12), a paint-absorbable member (14) and a movement coupler (16). The applicator (12) has a coupling portion (18) and two opposite ends (20, 22) and is rotatable at the coupling portion (18) about a rotary axis (24). The end (20) is a coupling end (20) that has a planar cross-section smaller than that of the other end (22). The coupling portion (18) is formed at the coupling end (20) and is disposed centrally thereat. The movement coupler (16) has a rotary connecting portion (40) that is detachably coupled to the applicator (12) at the coupling portion (40) that is detachably coupled to the applicator (12) at the coupling portion (18) for rotary movement about the rotary axis (24) and a pivotal connecting portion (42) that is adapted to coact with a pivot mount of a handle (not shown) for pivotal movement of the applicator (12).
Patent MX-PA04011812-A (MX)
Title: Device for influencing in a controlled manner the load pressure of pressure rollers.
Inventor: JOERN SOHLER
IPC: B21B13/14
Filed: 2003-04-30
Abstract: Disclosed is a device for influencing in a controlled manner the load-bearing force of supporting rollers (SW) that rest on working rollers. The neck (WZ) of said supporting rollers (SW) which is provided with an extension (ZA) is mounted in roller bearings or sliding bearings that are disposed in a bearing-supporting housing of the rollers of a roller stand. The neck extension (ZA) is mounted in a supporting bearing. The outside of the housing (LG) of said supporting bearing is connected to the bearing-supporting housing. An intermediate housing (ZG) which is inserted in the housing (LG) of the supporting bearing cylindrically encloses the supporting bearing, is impinged upon by a piston cylinder unit (RB, SK), and can be displaced within said housing (LG) in a radial direction relative to the axis of the neck extension (ZA).
Patent MX-PA05000831-A (MX)
Title: Shelf-stable, bakeable savory cheese product and process for preparing it.
Inventor: YAN ZHEN-YI
IPC: A21D10/00
Filed: 2002-07-19
Abstract: A savory, smooth-textured, bakeable and shef-stable product is prepared as a three-phase formulation, including an aqueous liquid phase, a dispersed fat phase and a solids phase, preferably containing cheese in significant proportion. The liquid phase is present in sufficient quantity to suspend and disperse the fat and solids phases. The dispersed fat must have sufficiently small droplet size raise the viscosity for this phase sufficiently to result in a creamy texture for the final product. The savory flavor ingredients are present as undissolved solids of sufficiently small particle size to provide the proper flavor release for the flavor and a texture consistent with the savory flavor. Preferred cheese products will have a lubricous, slippery, smooth mouthfeel and a flavor release that endures until the palate is essentially clean. The product can be applied to unbaked doughs prior to baking and retain their desired properties after baking The product can also be packaged for use as is with any number of complimentary foods. The product contains at least 5* of fate, less than 6% of water, an Aw of less than 0.5, a polyol as humectant and at least 3% of a solids phase containing cheese flavor or cheese solids.
Patent MX-PA05004512-A (MX)
Title: Inhibition of il-17 production.
Inventor: AUSTIN L GURNEY
IPC: G01N33/68
Filed: 2003-10-29
Abstract: The invention concerns inhibition of the production of proinflammatory cytokine Interleukin-17 (IL-17) by T cells, using an antagonist of interleukin-23 (IL-23). The invention further concerns the use of IL-23 antagonists in the treatment of inflammatory diseases characterized by the presence of elevated levels of IL-17. IL-23 antagonists include, without limitation, antibodies specifically binding to a subunit or IL-17 or an IL-17 receptor. The invention additionally concerns induction of IL-7 production by using an IL-23 agonist.
Patent MX-PA05005237-A (MX)
Title: Ca125 gene and its use for diagnostic and therapeutic interventions.
Inventor: UNDERWOOD LOWELL
IPC: C07K16/30
Filed: 2003-11-17
Abstract: The CA125 gene has been cloned and multiple repeat sequences as well as the carboxy terminus have been identified. The CA125 molecule comprises three major domains: an extracellular amino terminal domain (Domain 1); a large multiple repeat domain (Domain 2); and a carboxy terminal domain (Domain 3) which includes a transmembrane anchor with a short cytoplasmic domain. The amino terminal domain is assembled by combining five genomic exons, four very short amino terminal sequences and one extraordinarily large exon. This domain is dominated by its capacity for O-glycosylation and its resultant richness in serine and threonine residues. Additionally, an amino terminal extension is present, which comprises four genomic exons. The amino acid composition of the amino terminal extension was found to be consistent with the amino acid composition of the amino terminal domain. The molecular structure is dominated by a repeat domain comprising 156 amino acid repeat units, which encompass the epitope binding sites. More than 60 repeat units have been identified, sequenced, and contiguously placed in the CA125 domain structure. More specifically, this invention is directed to a CA125 cDNA sequence which can be introduced into animal or human cells to achieve transcription or expression of the cDNA.
Patent MX-PA05009240-A (MX)
Title: Transaction card providing displayed information.
Inventor: GARY M PURK
IPC: G06Q20/34
Filed: 2004-02-27
Abstract: Transaction cards useful for making purchases of goods and/or services are provided having a display for showing information thereon. More specifically, the transaction cards of the present invention provide information directly on the face of the transaction card that is received via a wireless chip and/or antenna embedded within the transaction card. The transaction cards may be "stored-value" cards, credit cards, debit cards, or other transaction cards. In addition, the transaction cards may store information thereon within one or more magnetic stripes and/or within microchips embedded within the transaction card. The information relates to credit limit information or balance information. Alternatively, the information may be displayed on means for holding the transaction card, such as a slipcover. In addition, the information may be requested and displayed on a portable communication device, such as a cellular telephone, a pager, a personal digital assistant, a personal computing device, or other like devices.
Patent MX-PA05010737-A (MX)
Title: 2-hydroxy-3-alkoxypropyl sulfides, sulfones, and sulfoxides: new surface active agents.
Inventor: PAULSEN EVELYN JENNIFER LIN
IPC: C09D7/47
Filed: 2005-10-05
Abstract: Compositions containing surfactant compounds according to formula (I) R4OCH2CH(OH)CR2R3ZR1 (I) wherein Z is S, SO, or SO2, can have a range of equilibrium and/or dynamic surface tensions and a range of foaming performance attributes, depending upon the particular values of Z, R,1, R2, R3, and R4. The compounds of formula (I) may be prepar ed by a process that includes reaction of a thiol with a glycidyl ether.
Patent MX-PA05012048-A (MX)
Title: Resuscitation training manikin.
Inventor: IANKE JENS PETTER
IPC: G09B23/28
Filed: 2004-05-07
Abstract: A manikin for practising resuscitation, comprising an inflatable body (1). The inflatable body (1) is adapted to absorb compression force exerted during simulated chest compression. Preferably, the manikin also comprises a chest plate (4), the chest plate (4) acting as a pressure distributor on the inflatable body (1). The chest plate (4) being connected to the inflatable body (1) by elastic means (22). The manikin may also comprise a lung part (2), the lung part being connected to a face mask (3). The lung (2) being adapted for inflation through the mouth and/or the nose of the face mask (3). The lung (2) having a chest portion ( 13) positioned substantially parallel to the chest portion (5) of the inflatable body (1). The face mask (3) being positioned at a head portion (7) of the inflatable body (1).
Patent MX-PA05012912-A (MX)
Title: Method and apparatus for saving energy in lighting systems comprising high-density (hid) gas discharge lamps.
Inventor: GARZA RAUL GERARDO QUINTERO DE
IPC: H01J15/04
Filed: 2005-11-30
Abstract: The present invention consists in a system for saving energy in the operation of a lighting system which can change from a fist level of full light to at least a second level of dim light, the system comprising at least a gas discharge lamp connected to an electric circuit which simultaneously comprises at least a ballast, and at least two capacitive elements: a first main capacitive element and a second complementary capacitive element; as well as a switch element, a TRIAC, connected in parallel to said second capacitive element. The TRIAC is connected in parallel to an inductive element. A discharge resistance pertaining to said second complementary capacitor is connected in parallel thereto for avoiding high currents, a varistor for protecting the TRIAC being connected in parallel to the TRIAC output for avoiding damages caused by an overvoltage, which may occur following a reconnection of the second capacitive element, thus protecting the switch body.
Patent MX-PA06000557-A (MX)
Title: Apparatus and method for providing an agc function using multiple feedback sources.
Inventor: HUTCHINSON DANIEL MARK
IPC: H04N5/46
Filed: 2004-07-08
Abstract: An apparatus (20) such as a television signal receiver provides an AGC function by using multiple feedback sources which provide both narrow band and wide band AGC signals in an adaptive manner. According to an exemplary embodiment, the apparatus (20) includes a tuner (10, 15, 20, 25, 30) operative to generate first and second IF signals. A first demodulator (40) is operative to generate a first AGC signal responsive to the first IF signal. A second demodulator (50) is operative to generate a second AGC signal responsive to the second IF signal. A wide band AGC detector (60) is operative to generate a third AGC signal responsive to at least one of the first and second IF signals. A switch (70) is operative to selectively provide one of the first, second and third AGC signals to the tuner (10, 15, 20, 25, 30) responsive to a predetermined condition.
Patent MX-PA06002441-A (MX)
Title: Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases.
Inventor: LERNER RICHARD A
IPC: A61K31/12
Filed: 2004-09-03
Abstract: As illustrated herein, cholesterol is oxidized when it is present in atherosclerotic plaques. This reaction generates cytotoxic cholesterol oxidation or ozonation products. The present application is directed to the products of cholesterol ozonation, binding entities directed against such products, and methods of using such binding entities and cytotoxins to treat a variety of diseases.
Patent MX-PA06004567-A (MX)
Title: Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein.
Inventor: KARP NELSON M
IPC: A61K39/12
Filed: 2004-10-25
Abstract: The present invention relates to an immunogenic composition. More particularly, the present invention is a composition directed to eliciting an immune response to at least one covalent binding site of myristate on the HIV matrix protein. The present invention contemplates three categories of embodiments: protein or protein fragments, messenger RNA, or DNA/RNA. DNA/RNA compositions may be either naked or recombinant. The present invention further contemplates use with a variety of immune stimulants.
Patent MX-PA06005672-A (MX)
Title: Compositions and methods for the diagnosis and treatment of tumor.
Inventor: ZEMIN ZHAN
IPC: C12N15/09
Filed: 2004-11-17
Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
Patent MX-PA06013230-A (MX)
Title: Method for manufacturing a diagnostic test strip.
Inventor: JUNG SUNG-KWON
IPC: G01N27/00
Filed: 2005-05-13
Abstract: A method for manufacturing a diagnostic test strip is disclosed according to one embodiment. The method includes the acts of providing an application sheet (16) having a plurality of adhesive dots (13) thereon, providing a first substrate layer (14) having at least one feature (15) located thereon, and providing a second substrate layer. The method further including the acts of transferring at least one of the plurality of adhesive dots located on the application sheet to the first substrate layer, aligning the first substrate layer with the second substrate layer, and attaching the first substrate layer and the second substrate layer using the transferred adhesive dots, wherein the attaching of the first and second substrate layers is performed without any additional alignment.
Patent MY-103919-A (MY)
Title: Mutant resistant to cell membrane synthesis inhibitor and process for preparing the same.
Inventor: SUSUMO ITO
IPC: C12N9/54
Filed: 1988-09-29
Abstract: A MUTANT OF AN EXTRACELLULAR ENZYME-PRODUCING MICROORGANISM BELONGING TO GENUS BACILLUS, WHICH IS RESISTANT TO A CELL MEMBRANE SYNTHESIS INHIBITOR, INCLUDING VANCOMYCIN AND RISTOCETIN, IS DISCLOSED. THE CELL MEMBRANE SYNTHESIS INHIBITOR-RESISTANT MUTANT CAN PRODUCE SUCH AN ENZYME AS CELLULASE, PROTEASE, OR AMYLASE ABOUT 2 TO 4 TIMES OF THE PARENT STRAIN. SUCH A MUTANT CAN BE PRODUCED BY SUBJECTING AN EXTRACELLULAR ENZYME-PRODUCING MICROORGANISM TO A MUTATION TREATMENT, AND CULTURING SAID MICROORGANISM IN A CULTURE MEDIUM CONTAINING A CELL MEMBRANE SYNTHESIS INHIBITOR.
Patent MY-103450-A (MY)
Title: Glass fiber reinforced thermoplastic resin compositions
Inventor: YUKIO YOSHIHARA
IPC: C08K7/00
Filed: 1988-11-01
Abstract: A GLASS FIBER REINFORCED POLYPROPYLENE-POLYAMIDE RESIN COMPOSITION WHICH COMPRISES:(A)A PROPYLENE-ETHYLENE BLOCK COPOLYMER OF AN ETHYLENE CONTENT OF 5-30 MOLE AND OF MELT FLOW RATE OF NOT LESS THAN 1.5 G/10 MINUTES IN AMOUNTS OF 25-65% BY WEIGHT; AND (B)A POLYAMIDE IN AMOUNTS OF 75-35% BY WEIGHT; THE PROPYLENE-ETHYLENE BLOCK COPOLYMER AND THE POLYAMIDE AMOUNTING TO 100WEIGHT; AND (C)GLASS FIBERS IN AMOUNTS OF 10-100 PARTS BY WEIGHT IN RELATION TO 100 PARTS BY WEIGHT OF THE TOTAL OF THE PROPYLENE-ETHYLENE BLOCK COPOLYMER AND THE POLYAMIDE; (D)A GRAFTED POLYPROPYLENE WHICH HAS AN UNSATURATED CARBOXYLIC ACID OR ITS DERIVATIVES GRAFTED THEREONTO IN AMOUNTS OF 0.5-5 PARTS BY WEIGHT IN RELATION TO 100 PARTS BY WEIGHT OF THE TOTAL OF THE PROPYLENE-ETHYLENE BLOCK COPOLYMER AND POLYAMIDE; AND (E)AN ORGANIC PEROXIDE IN AMOUNTS OF 0.02-0.5% BY WEIGHT BASED ON THE PROPYLENE-ETHYLENE BLOCK COPOLYMER.
Patent MY-105250-A (MY)
Title: Fm receiver.
Inventor: JENS HANSEN
IPC: H04B1/18
Filed: 1989-05-30
Abstract: FM RECEIVER INCLUDING MEANS FOR CONTROLLING THE CENTER FREQUENCY OF AN IF FILTER, WHICH IS RELATIVELY NARROWBANDED WITH RESPECT TO THE CHANNEL BANDWIDTH, AS A FUNCTION OF THE DESIRED MODULATION, THE RECEIVER COMPRISING A SIGNAL PROCESSING UNIT INCLUDING AND IF UNIT AND AN LF UNIT FOR AMPLIFYING , FREQUENCY CONVERTING AND DEMODULATING THE RECEIVED FM SIGNAL, A CIRCUIT FOR CHANGING THE SIGNAL TRANSMISSION CHARACTERISTIC OF THE IF AND/OR LF UNIT, INCLUDING A SIGNAL DETECTION UNIT AND CIRCUITS FOR DETECTING VALUES CHARACTERISTIC OF RECEIVING OR INTERFERENCE STATES, WITH THE INPUTS OF THESE CIRCUITS EACH BEING CONNECTED WITH A CIRCUIT POINT OF THE IF OR LF UNIT CARRYING THE SIGNAL TO BE PROCESSED AND OUTPUTS FOR SIGNALS CHARACTERIZING RECEIVING OR INTERFERENCE STATES, A SIGNAL PROCESSING UNIT FOR THE SIGNAL CHARACTERISTIC OF RECEIVING AND INTERFERENCE STATES, SAID UNIT INCLUDING AT LEAST ONE AMPLITUDE AND/OR THRESHOLD CIRCUIT WHOSE INPUTS ARE CONNECTED WITH THE OUTPUTS OF THE SIGNAL DETECTION UNIT AND A SIGNAL OUTPUT UNIT FOR PUTTING OUT THE PROCESSED SIGNALS CHARACTERISTIC OF RECEIVING AND INTERFERENCE STATES AS CONTROL SIGNALS FOR INFLUENCING THE PROCESSING CHARACTERISTIC OF THE SIGNAL PROCESSING UNIT TO INDIVIDUAL STAGES OF THE IF OR LF UNIT, WITH INPUTS OF THE SIGNAL OUTPUT UNIT BEING CONNNECTED WITH OUTPUTS OF THE SIGNAL PROCESSING UNIT AND THE OUTPUTS OF THE SIGNAL OUTPUT UNIT ARE CONNECTED WITH CONTROL INPUTS OF STAGES OF THE IF OR LF UNIT RESPECTIVELY. (FIGURE 1A)
Patent MY-105822-A (MY)
Title: Combined use of n-imidazolyl derivatives of bicyclic compounds and cyclosporine in therapy.
Inventor: CORRADO FERTI
IPC: A61K31/415
Filed: 1990-06-22
Abstract: THE INVENTION RELATES TO THE USE OF N-IMIDAZOLYL DERIVATIVES OF BICYCLIC COMPOUNDS OF GENERAL FORMULA WHEREIN Y COMPLETES A SINGLE BOND OR IS OXYGEN OR A -CH2-GROUP AND THE SYMBOL REPRESENTS A SINGLE OR A DOUBLE BOND OR (B) AND THE SYMBOL - - - - REPRESENTS A DOUBLE BOND; ONE OF R1,R2,R3 AND R4 IS -CH2OH2 C2-C4 ACYL,IN WHICH EACH OF R7, R8 AND R9 IS INDEPENDENTLY HYDROGEN OR C1-C4 ALKYL, AND THE OTHERS ARE INDEPENDENTLY CHOSEN FROM HYDROGEN, HYDROXY, HALOGEN, C1-C4 ALKYL, C1-C4 ALKOXY AND COOR7 WHEREIN R7 IS AS DEFINED ABOVE; AND ONE OF R5 AND R6 IS HYDROGEN AND THE OTHER IS HYDROGEN, C1-C6 ALKYL OR PHENYL; OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR IN COMBINATION WITH CYCLOSPORIN A. THE COMPOUNDS OBTAINED ARE USEFUL IN PREVENTING AND/OR TREATING CYCLOSPORINE A-INDUCED NEPHROSIS IN MAMMALS.
Patent MY-109234-A (MY)
Title: Prepolymeric epoxy resin mixture containing oxazolidinone structures
Inventor: BRAUN PETER
IPC: C08G59/40
Filed: 1993-07-14
Abstract: IN A PROCESS FOR THE PREPARATION OF A PREPOLYMERIC EPOXY RESIN (EPOXIDE VALUE 5.78 MOL/KG) MIXTURE CONTAINING OXAZOLIDINONE STRUCTURES (EPOXIDE VALUE : 0.89 MOL/KG, MELTING RANGE : 75 TO 95?C ), A FILLER-CONTAINING, THERMALLY POLYMERISABLE REACTION RESIN MIXTURE OF POLYEPOXY RESIN, COMPRISING A MIXTURE OF DI- AND POLYFUNCTIONAL EPOXY RESINS, AND POLYISOCYANATE RESIN HAVING A MOLAR RATIO OF EPOXY GROUPS TO ISOCYANATE GROUPS (IN THE REACTION RESIN MIXTURE) OF > 1 IS FED TO A CONTINUOUS REACTOR. THE REACTION RESIN MIXTURE IS THEN REACTED - WITH THE USE OF SUBSTITUTED IMIDAZOLE AS A REACTION ACCELERATOR, HAVING A CONTENT OF 0.5 TO 2.5% , BASED ON THE POLYEPOXY RESIN - AT REACTION TEMPERATURES UP TO 200?C, THE TEMPERATURE OF THE REACTOR BEING 140 TO 190?C, AND THE EXTRUDATE IS THEN COOLED TO A TEMPERATURE OF < 50?C WITH THE AID OF A COOLING APPARATUS MOUNTED AT THE OUTLET NOZZLE OF THE REACTOR.
Patent MY-112299-A (MY)
Title: Receptacle unit and extension cord
Inventor: TERUHIKO ISHINAKA
IPC: G08B21/00
Filed: 1995-10-17
Abstract: AN ELECTRICAL RECEPTACLE UNIT INCLUDES AT LEAST ONE RECEPTACLE BODY (3) INTERNALLY PROVIDED WITH A PAIR OF SLOTTED TERMINALS (4) FOR INSERTION OF A PAIR OF BLADES (L) OF A LOAD-SIDE ELECTRICAL PLUG (P), A THERMISTOR (7) ENCASED IN A PROTECTIVE TUBE (9) OUTWARDLY PROJECTABLE FROM BETWEEN THE SLOTTED TERMINALS (4) OF THE RECEPTACLE BODY (3), A COIL SPRING (13) FOR PROJECTING THE THERMISTOR (7) OUT FROM THE RECEPTACLE BODY (3), A RELAY (14) FOR ENABLING AND DISABLING SUPPLY OF ELECTRIC POWER TO THE SLOTTED TERMINALS (4), A CONTROL CIRCUIT (19) WHICH OPERATES THE RELAY (14) TO CUT OFF SUPPLY OF ELECTRIC POWER TO THE SLOTTED TERMINALS (4) WHEN THE TEMPERATURE OF THE THERMISTOR (7) REACHES OR EXCEEDS A PRESET TEMPERATURE, AND A BUZZER (23) OPERATED BY AN OUTPUT SIGNAL PRODUCED BY THE CONTROL CIRCUIT (19) WHEN THE TEMPERATURE OF THE THERMISTOR (7) REACHES OR EXCEEDS THE PRESETTEMPERATURE. WHEN THE THERMISTOR RISES TO OR ABOVE THE PRESET TEMPERATURE OWING TO TRACKING OR THE LIKE, SUPPLYOF POWER TO THE LOAD-SIDE PLUG IS CUT OFF AND THE ALARM IS ACTIVATED TO PRODUCE A WARNING THAT THE LOAD-SIDE PLUG HAS OVERHEATED.(FIG. 1)
Patent MY-127822-A (MY)
Title: Ectoparasiticidal aqueous suspension formulations.
Inventor: THOMPSON WILLIAM WEBSTER
IPC: A61K47/10
Filed: 2000-08-11
Abstract: THE INVENTION PROVIDES A STABLE ESTOPARASITICIDAL AQUEOUS SUSPENSION FORMULATION OF A SPINOSYN, COMPRISING THE SPINOSYN, OR A PHYSIOLOGICALLY SCCEPTABLE DERIVATIVES OR SALT THEREOF, MILLED TO AN AVERAGE PARTICLE SIZE OF 1 TO 15 MICRONS, A SURFACTANT IN AN AMOUNT EFFECTIVE TO FACILITATE WETTING THE MILLED PARTICLES; A DISPERSANT IN AN AMOUNT THAT FORMS A SPINOSYN; DISPERSNT WEIGHT RATION OF FROM 3:1 TO 1:5 ; AND WATER . IT ALSO PROVIDES A METHOD OF CONTROLLING AN ECTOPARASITE INFESTATION ON A SMALL RUMINANT OR COMPANION ANIMAL COMRPISING ADMINISTERING AN EFFECTIVE AMOUNT OF SUCH AN AQUEOUS SUSPENSION FORMULATION .